DE69910019D1 - Verwendung von derivaten der 2-hydroxy-4-trifluormethylbenzoe säure als hemmer der aktivierung des nuklearischen transkriptionsfaktors nf-(k)b - Google Patents
Verwendung von derivaten der 2-hydroxy-4-trifluormethylbenzoe säure als hemmer der aktivierung des nuklearischen transkriptionsfaktors nf-(k)bInfo
- Publication number
- DE69910019D1 DE69910019D1 DE69910019T DE69910019T DE69910019D1 DE 69910019 D1 DE69910019 D1 DE 69910019D1 DE 69910019 T DE69910019 T DE 69910019T DE 69910019 T DE69910019 T DE 69910019T DE 69910019 D1 DE69910019 D1 DE 69910019D1
- Authority
- DE
- Germany
- Prior art keywords
- hydroxy
- transcription factor
- derivatives
- trifluormethylbeneoic
- inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Transplantation (AREA)
- Hospice & Palliative Care (AREA)
- Virology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9801154 | 1998-05-27 | ||
ES009801154A ES2136581B1 (es) | 1998-05-27 | 1998-05-27 | Uso de derivados del acido-2-hidroxi-4-trifluorometilbenzoico para la preparacion de medicamentos utiles para inhibir el factor de transcripcion nuclear nf-kb. |
PCT/ES1999/000154 WO1999061030A1 (es) | 1998-05-27 | 1999-05-26 | USO DE DERIVADOS DEL ACIDO 2-HIDROXI-4-TRIFLUOROMETILBENZOICO COMO INHIBIDORES DE LA ACTIVACION DEL FACTOR DE TRANSCRIPCION NUCLEAR NF-λB |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69910019D1 true DE69910019D1 (de) | 2003-09-04 |
DE69910019T2 DE69910019T2 (de) | 2004-05-06 |
Family
ID=8304002
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69910019T Expired - Fee Related DE69910019T2 (de) | 1998-05-27 | 1999-05-26 | Verwendung von derivaten der 2-hydroxy-4-trifluormethylbenzoe säure als hemmer der aktivierung des nuklearischen transkriptionsfaktors nf-(k)b |
Country Status (14)
Country | Link |
---|---|
US (2) | US6414025B1 (de) |
EP (2) | EP1362592A1 (de) |
JP (1) | JP2002516283A (de) |
KR (2) | KR100762156B1 (de) |
AT (1) | ATE245987T1 (de) |
AU (1) | AU3828699A (de) |
BR (1) | BR9911598A (de) |
CA (1) | CA2332863A1 (de) |
DE (1) | DE69910019T2 (de) |
DK (1) | DK1082962T3 (de) |
ES (2) | ES2136581B1 (de) |
NO (1) | NO20005981L (de) |
PT (1) | PT1082962E (de) |
WO (1) | WO1999061030A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2154242B1 (es) * | 1999-09-03 | 2001-10-16 | Uriach & Cia Sa J | Nuevos sistemas polimericos biocompatibles portadores de triflusal o htb. |
US20040101488A1 (en) * | 2000-03-24 | 2004-05-27 | Balaram Ghosh | Method for the prevention of septic shock lethality using curcumin |
ES2190373B1 (es) * | 2001-12-07 | 2004-10-16 | J. URIACH & CIA, S.A. | Uso del acido 2-hidroxi- o 2-acetiloxi-4-trifluorometilbenzoico como agente para el tratamiento y prevencion del deterioro cognitivo ligero. |
MXPA05003063A (es) | 2002-09-20 | 2005-05-27 | Alcon Inc | Uso de inhibidores de la sintesis de citosina para el tratamiento de trastornos de ojos secos. |
KR101701404B1 (ko) * | 2008-05-28 | 2017-02-01 | 레베라겐 바이오파마 인코포레이티드 | 질환의 치료를 위한 NF-κB 의 비호르몬성 스테로이드 조절제 |
CA3146333A1 (en) * | 2009-03-18 | 2010-09-23 | Resverlogix Corp. | Phenyl-quinazolin-4(3h)-one and phenyl-pyrido[2,3-d]pyrimidin-4(3h)-one derivatives and compositions thereof useful as anti-inflammatory agents |
WO2011127048A2 (en) | 2010-04-05 | 2011-10-13 | Validus Biopharma | NON-HORMONAL STEROID MODULATORS OF NF-ĸB FOR TREATMENT OF DISEASE |
CN103665012B (zh) * | 2013-12-06 | 2016-06-22 | 辽宁师范大学 | 新型三氟柳无机药物化合物及合成方法 |
US10799514B2 (en) | 2015-06-29 | 2020-10-13 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-kappa beta for treatment of disease |
US20180016314A1 (en) * | 2016-07-12 | 2018-01-18 | Children's Hospital Medical Center | Treatment of disease via transcription factor modulation |
KR101975603B1 (ko) | 2018-09-14 | 2019-08-28 | 이영문 | 조력 발전장치 |
US11382922B2 (en) | 2019-03-07 | 2022-07-12 | Reveragen Biopharma, Inc. | Aqueous oral pharmaceutical suspension compositions |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4096252A (en) * | 1976-06-10 | 1978-06-20 | J. Uriach & Cia S.A. | 4-Trifluoromethylbenzoic acid derivatives as thromboembolic agents |
IT1276071B1 (it) * | 1995-10-31 | 1997-10-24 | Nicox Ltd | Compositi ad attivita' anti-infiammatoria |
-
1998
- 1998-05-27 ES ES009801154A patent/ES2136581B1/es not_active Expired - Fee Related
-
1999
- 1999-05-26 EP EP03012255A patent/EP1362592A1/de not_active Withdrawn
- 1999-05-26 DK DK99920872T patent/DK1082962T3/da active
- 1999-05-26 WO PCT/ES1999/000154 patent/WO1999061030A1/es active IP Right Grant
- 1999-05-26 PT PT99920872T patent/PT1082962E/pt unknown
- 1999-05-26 US US09/701,270 patent/US6414025B1/en not_active Expired - Fee Related
- 1999-05-26 DE DE69910019T patent/DE69910019T2/de not_active Expired - Fee Related
- 1999-05-26 CA CA002332863A patent/CA2332863A1/en not_active Abandoned
- 1999-05-26 KR KR1020067026281A patent/KR100762156B1/ko not_active IP Right Cessation
- 1999-05-26 ES ES99920872T patent/ES2204129T3/es not_active Expired - Lifetime
- 1999-05-26 KR KR1020007013316A patent/KR100713601B1/ko not_active IP Right Cessation
- 1999-05-26 JP JP2000550490A patent/JP2002516283A/ja active Pending
- 1999-05-26 AU AU38286/99A patent/AU3828699A/en not_active Abandoned
- 1999-05-26 BR BR9911598-0A patent/BR9911598A/pt not_active Application Discontinuation
- 1999-05-26 AT AT99920872T patent/ATE245987T1/de not_active IP Right Cessation
- 1999-05-26 EP EP99920872A patent/EP1082962B1/de not_active Expired - Lifetime
-
2000
- 2000-11-27 NO NO20005981A patent/NO20005981L/no not_active Application Discontinuation
-
2002
- 2002-04-04 US US10/115,140 patent/US6610745B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2332863A1 (en) | 1999-12-02 |
KR20010052404A (ko) | 2001-06-25 |
DK1082962T3 (da) | 2003-11-24 |
ES2136581B1 (es) | 2000-09-16 |
KR100713601B1 (ko) | 2007-05-02 |
PT1082962E (pt) | 2003-11-28 |
US6414025B1 (en) | 2002-07-02 |
EP1082962A1 (de) | 2001-03-14 |
ES2204129T3 (es) | 2004-04-16 |
JP2002516283A (ja) | 2002-06-04 |
US20030032630A1 (en) | 2003-02-13 |
AU3828699A (en) | 1999-12-13 |
ATE245987T1 (de) | 2003-08-15 |
EP1082962B1 (de) | 2003-07-30 |
US6610745B2 (en) | 2003-08-26 |
WO1999061030A1 (es) | 1999-12-02 |
NO20005981L (no) | 2000-12-12 |
ES2136581A1 (es) | 1999-11-16 |
DE69910019T2 (de) | 2004-05-06 |
KR100762156B1 (ko) | 2007-10-04 |
EP1362592A1 (de) | 2003-11-19 |
KR20070006943A (ko) | 2007-01-11 |
NO20005981D0 (no) | 2000-11-27 |
BR9911598A (pt) | 2001-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9806752A (pt) | Ftalazinonas. | |
DE69910019D1 (de) | Verwendung von derivaten der 2-hydroxy-4-trifluormethylbenzoe säure als hemmer der aktivierung des nuklearischen transkriptionsfaktors nf-(k)b | |
DE69816280D1 (de) | Inhibitoren des impdh-enzyms | |
NO20003233D0 (no) | 4-hydrokykinolin-3-karboksamider og hydraziner som antivirale midler | |
ATE199552T1 (de) | Substituierte benzolaktamverbindungen als substanz-p-antagonisten | |
SE9103752D0 (sv) | New compounds | |
DE69512930T2 (de) | Stilben-derivate verwendbar als cyclooxygenase-2 hemmer | |
EA199800667A1 (ru) | Новые фенантридины | |
ES2176252T3 (es) | Benzamidas sustituidas con fluoro-alcoxi y su utilizacion como agentes inhibidores de fosfodiesterasas de nucleotidos ciclicos. | |
NO971766D0 (no) | Anvendelsen av dioksomorfoliner for bekjempning av endoparasitter, nye dioksomorfoliner samt deres fremstilling | |
DE69531623D1 (de) | Neue benzoxazole | |
ID23877A (id) | Senyawa-senyawa dan metode-metode untuk penghambatan ekspresi vcam-1 | |
TR200200205T2 (tr) | MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi | |
BR0007527A (pt) | Fenilfenantridinas com atividade inibitória depde-iv | |
NO962568L (no) | Anvendelse av PLA2 inhibitorer som behandling for Alzheimers sykdom | |
TR199800585T2 (xx) | COX-2 �nhibit�rleri Olarak (Metils�lfonil)Fenil-2-(5H)-Furanonlar. | |
DK0937074T3 (da) | Benzonaphthyridiner som bronkiale terapeutiske midler | |
EP0786995A4 (de) | ||
ATE154347T1 (de) | Benzisothiazolinon-1-dioxyde als elastase- inhibitoren | |
BR0315662A (pt) | Derivados de 1-(4-benzil-piperazin-1-il)-3-fenil-propenona | |
ATE516027T1 (de) | Orazamid orotat zur vorbeugung von leberschäden | |
TR199902094T2 (xx) | 3-Heteroareil-4(3H)-kinazolinonlar�n atropizomerleri. | |
DE59808166D1 (de) | Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure als mukolytikum | |
WO1998052548A3 (de) | Verwendung von 1-ar(alk)yl-imidazolin-2-one zur behandlung von angst- und spannungszuständen | |
DK0966455T3 (da) | Oxirancarboxylsyrer til behandling af diabetes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |